T/CMBA 013-2021 Specification for hospital in management of clinical application of chimeric antigen receptor T cell marketed products (English Version)
This document stipulates the facilities and equipment, personnel, systems and procedures, quality management, treatment, records and labeling for the use of CAR-T cell therapy products in medical institutions.
T/CMBA 013-2021 history
2021T/CMBA 013-2021 Specification for hospital in management of clinical application of chimeric antigen receptor T cell marketed products